Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher, Winvale Group Ink Informatics Partnership

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Winvale Group, a government procurement and consulting organization specializing in government procurement and the General Services Agency Schedule program, has partnered with Thermo Fisher Scientific to help it land informatics customers that are using stimulus funding, Thermo Fisher said today.

As part of Thermo Fisher's Informatics Global Partner Alliance, Winvale will help Thermo Fisher navigate the GSA Schedule 70 information technology contracting process.

Winvale also will ensure that Thermo Fisher's informatics solutions, such as its laboratory information management systems or chromatography data systems can be acquired using funding from the American Recovery and Reinvestment Act of 2009.

Thermo Fisher said that the partnership is part of its efforts to "reach the critical audience of federal, state, and local laboratories that require IT solutions to manage a full range of scientific and laboratory research, from public health and safety laboratories to drinking water and public sanitation, environmental and state and federal research institutes."

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.